The Promise and Challenge of Molecular Diagnostics

Abstract

Get full access to this article

View all access options for this article.

References

List of Cleared or Approved Companion Diagnostics Devices (In Vitro and Imaging Tools), The United States Food and Drug Administration (FDA). Accessed: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm on 17th October 2014

World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 1.1. ISBN 9283204298.

Brink

, de Goeij

, Weijenberg

et al. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis, 2003; 24:703–710.

External Quality Assessment for KRAS Testing Is Needed: Setup of a European Program and Report of the First Joined Regional Quality Assessment Rounds, The Oncologist, 2011; 16:467–478